Francisca Chavez Ruvalcaba

Dr. Francisca Chavez Ruvalcaba

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 January 2017 in Parasite Immunology
Verified
Journal Article
Closed access
PDF file
José Luis Muñoz-CarrilloJosé Luis Muñoz-Carrillo
José Luis Muñoz-Carrillo
JMJ. J. Muñoz‐Escobedo
J. J. Muñoz‐Escobedo
CMC. H. Maldonado‐Tapia
C. H. Maldonado‐Tapia
FRFrancisca Chavez Ruvalcaba
Francisca Chavez Ruvalcaba
MMM. A. Moreno‐García
M. A. Moreno‐García

1 August 2018
Verified
Book Chapter
Open access
PDF file
José Luis Muñoz-CarrilloJosé Luis Muñoz-Carrillo
José Luis Muñoz-Carrillo
FCFlor Pamela Castro-García
Flor Pamela Castro-García
FRFrancisca Chavez Ruvalcaba
Francisca Chavez Ruvalcaba
ICIsabel Chávez-Rubalcaba
Isabel Chávez-Rubalcaba
JMJosé Luis Martínez-Rodríguez
José Luis Martínez-Rodríguez
MHMarcela Elizabeth Hernández-Ruiz
Marcela Elizabeth Hernández-Ruiz
The immune response is known as a physiological mechanism to protect the body, providing defense to different systems that compose it and allowing its proper functioning. The ability to keep the organism free from foreign agents depends on the mechanisms of natural resistance or innate immunity, as well as the resistance that can develop over time through adaptive immunity. However, when these defense mechanisms fail, it can trigger injuries and diseases in the tissues, such as hypersensitivity, which is characterized as an excessive and undesirable reaction, produced by the immune system; as well as autoimmunity, which refers to the failure of the mechanisms of immunological tolerance, causing the reaction of the immune system against the body itself.

Verified
Journal Article
Open access
PDF file
RMRenata Morales-Márquez
Renata Morales-Márquez
LDLucía Delgadillo-Ruiz
Lucía Delgadillo-Ruiz
Alfredo Esparza-OrozcoAlfredo Esparza-Orozco
Alfredo Esparza-Orozco
EDEladio Delgadillo
Eladio Delgadillo
RBRómulo Bañuelos-Valenzuela
Rómulo Bañuelos-Valenzuela
LHLuz Adriana Arias Hernández
Luz Adriana Arias Hernández
The use of medicinal plants represents an alternative method for bacterial control due to their chemical compositions. This study’s objective was to determine the inhibitory capacity of Larrea tridentata extracts against microbial strains of clinical interest. Four extracts were prepared, their phytochemical profiles were determined, and their antioxidant capacities were quantified. Additionally, the minimum concentrations of hemolysis were determined using human blood erythrocytes. For the extracts’ growth inhibitory capacity, six bacterial and two fungal strains were evaluated using the disk diffusion test. Commercial medications specific for each strain were used as controls. The ethanolic extracts registered the greatest diversity of metabolites related to antibacterial activity. The inhibitory activities of the ethanolic extract and the Cedax® control were similar for Enterococcus faecalis. A principal component analysis was performed with X2 and ANOVA tests to identify the relationships and the effects of the extracts on bacterial inhibition, obtaining p > 0.05 with a confidence level of 95%. This research highlights the potential of L. tridentata extracts as an alternative treatment and to mitigate the growing problem of resistance to traditional antibiotics.

Verified
Journal Article
Open access
PDF file
José Luis Muñoz-CarrilloJosé Luis Muñoz-Carrillo
José Luis Muñoz-Carrillo
Oscar Gutiérrez-CoronadoOscar Gutiérrez-Coronado
Oscar Gutiérrez-Coronado
Paola Trinidad Villalobos  GutiérrezPaola Trinidad Villalobos Gutiérrez
Paola Trinidad Villalobos Gutiérrez
MVMarcelo Stalin Villacis-Valencia
Marcelo Stalin Villacis-Valencia
FRFrancisca Chavez Ruvalcaba
Francisca Chavez Ruvalcaba
JBJoshuan J. Barboza
Joshuan J. Barboza
The inflammatory response plays a central role in the pathophysiology of various chronic diseases such as periodontitis, type 2 diabetes mellitus (T2DM), and coronavirus disease 2019 (COVID-19), whose coexistence is associated with an increase in clinical complications and a more severe and serious course of these diseases. Current evidence on the interrelationship between periodontitis, T2DM, and COVID-19 remains insufficient, highlighting the need for further research to elucidate these associations. The main aim of this narrative review is to provide the current landscape of the most relevant aspects of the interrelationship between periodontitis, T2DM, and COVID-19. This narrative review was carried out through a specialized, exhaustive, and structured search of published studies indexed in the electronic databases PubMed and LILACS, for the inclusion of studies in English and Spanish, respectively, without date restriction. A search strategy was performed using the Boolean operators AND, OR, and NOT, with the following DeCS/MeSH terms: “periodontal disease”, “periodontitis”, “type 2 diabetes mellitus”, “SARS-CoV-2”, and “COVID-19”. A variety of articles were included, focusing on the most relevant aspects of the interrelationship between periodontitis, T2DM, and COVID-19. Findings suggest that inflammation is a unifying mechanism, which leads to the severity of these conditions through four shared axes: (1) a clinicopathological axis involving systemic manifestations; (2) an axis associated with metabolic alterations linked to glycemic dysregulation; (3) an axis related to enzyme overexpression linked to altered angiotensin-converting enzyme (ACE)-2 expression and glucose metabolism; and (4) an inflammatory axis. These synergistic interactions can cause these three diseases to mutually enhance each other, creating a vicious cycle, worsening the patient’s health.

1 May 2017 in Acta Biológica Colombiana
Verified
Journal Article
Open access
PDF file
FRFrancisca Chavez Ruvalcaba
Francisca Chavez Ruvalcaba
MRMaría Isabel Chávez Ruvalcaba
María Isabel Chávez Ruvalcaba
CLCarlos Eduardo Hernández Luna
Carlos Eduardo Hernández Luna
JEJosé Jesús Muñoz Escobedo
José Jesús Muñoz Escobedo
José Luis Muñoz-CarrilloJosé Luis Muñoz-Carrillo
José Luis Muñoz-Carrillo
MGMaría Alejandra Moreno García
María Alejandra Moreno García
La trichinellosis es una enfermedad parasitaria zoonótica y cosmopolita, se debe al consumo de carne deficientemente cocida, principalmente proveniente del cerdo, diversos estudios avalan la eficacia de la administración de inmunoterapia. Se ha caracterizado un antígeno inmunodominante de 45 kDa y se plantea como objetivo evaluar la presencia de anticuerpos IgA, IgM e IgG anti-Trichinella spiralis a lo largo de la infección, así como el comportamiento en la administración de la inmunización de 45 kDa de Trichinella spiralis (T. spiralis) administrado por vía sublingual y vía parenteral. Se utilizaron 36 murinos (Long Evans), seis para la infección y purificación del antígeno de 45 kDa, 30 para formar los grupos de trabajo, control sano (cinco murinos), control infectado (cinco murinos), y 20 para los grupos experimentales, se inmunizaron dos grupos con cuatro dosis (0, 7, 14 y 21 días) del inmunógeno de 45 KDa de T. spiralis, uno por vía sublingual y otro por vía parenteral y se retaron con 500 larvas infectantes (LI) de T. spiralis siete días después de la ultima inmunización y dos grupos más se infectaron con 500 LI y se inmunizaron a las cuatro semanas postinfección por ambas vías. La respuesta se evaluó por inmunofluorescencia indirecta (IFI) por microscopia confocal para determinar la respuesta humoral con anticuerpos de clase IgG, IgM e IgA.

8 November 2024 in Preprints.org
Verified
Preprint
Open access
PDF file
José Luis Muñoz-CarrilloJosé Luis Muñoz-Carrillo
José Luis Muñoz-Carrillo
PPPaulo Israel Palomeque-Molina
Paulo Israel Palomeque-Molina
MVMarcelo Stalin Villacis-Valencia
Marcelo Stalin Villacis-Valencia
Oscar Gutiérrez-CoronadoOscar Gutiérrez-Coronado
Oscar Gutiérrez-Coronado
FRFrancisca Chavez Ruvalcaba
Francisca Chavez Ruvalcaba
JPJosue Palomeque-Molina
Josue Palomeque-Molina
Inflammation plays a fundamental role in the development and bidirectional association of diverse diseases, such as periodontitis and type 2 diabetes mellitus, which generates important clinical complications, where chronic exposure to high levels of blood glucose affects the repair process of periodontal tissues. Likewise, it has been observed that comorbidity, between these two diseases, influences the development of the COVID-19 disease towards a more severe course. However, there is currently very little scientific evidence on the relationship between periodontitis, type 2 diabetes mellitus and COVID-19 disease. This narrative review aims to provide an understanding of the current and most relevant aspects of the relationship between periodontitis, type 2 diabetes mellitus and COVID-19 disease. A narrative review was performed through a systematic search of published studies, without date restrictions, indexed in the electronic databases of PubMed, for the inclusion of articles in English, and LILACS for the inclusion of articles in Spanish. This review included different articles, which addressed the most important aspects to present a current perspective on the relationship and influence between periodontitis, type 2 diabetes mellitus and COVID-19 disease. Comorbidity between periodontitis and type 2 diabetes mellitus represents a greater risk of developing a more severe course of COVID-19 disease, because these three diseases share three important axes: a clinicopathological axis; an axis associated with glycemia, and an immunological axis associated with inflammation.